Biodexa Pharmaceuticals annual free cash flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Biodexa Pharmaceuticals Free Cash Flow (FCF) History (BDRX)
Biodexa Pharmaceuticals reported −£5.6M in free cash flow for fiscal 2025, an increase of £6.7M from the previous fiscal year.
View full Biodexa Pharmaceuticals company overviewBiodexa Pharmaceuticals free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −£5.6M | £6.7M | — | — |
| 2024 | 2024-12-31 | −£12.3M | −£5.4M | — | — |
| 2023 | 2023-12-31 | −£6.9M | £258,000 | — | −1798.43% |
| 2022 | 2022-12-31 | −£7.1M | −£782,000 | — | −1017.17% |
| 2021 | 2021-12-31 | −£6.3M | £3.2M | — | −1094.81% |
| 2020 | 2020-12-31 | −£9.5M | −£2.7M | — | −2772.59% |
| 2019 | 2019-12-31 | −£6.8M | £6.9M | — | −1008.75% |
| 2018 | 2018-12-31 | −£13.7M | −£34,000 | — | −706.60% |
| 2017 | 2017-12-31 | −£13.7M | £773,000 | — | −1381.19% |
| 2016 | 2016-12-31 | −£14.4M | −£1.1M | — | −1090.93% |
| 2015 | 2015-12-31 | −£13.3M | — | — | −970.40% |
Biodexa Pharmaceuticals quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Biodexa Pharmaceuticals free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −£9.5M to −£5.6M, a net increase of £3.9M.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Biodexa Pharmaceuticals filings at SEC.gov ↗